Cargando…
Rewiring Tumor Cell State in Cancer Therapy: Comment on ‘9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts’ by ‘Elizabeth Beierle et al.’
Autor principal: | Chakraborty, Abhishek A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718159/ https://www.ncbi.nlm.nih.gov/pubmed/33276293 http://dx.doi.org/10.1016/j.tranon.2020.100967 |
Ejemplares similares
-
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
por: Marayati, Raoud, et al.
Publicado: (2020) -
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
por: Williams, Adele P., et al.
Publicado: (2019) -
More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer
por: Chelvanambi, Manoj, et al.
Publicado: (2021) -
What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
por: Holst, Jens Juul
Publicado: (2021) -
T cell biomarkers come to the fore in cancer immunotherapy
por: Sheriff, Lozan, et al.
Publicado: (2023)